Clinical Trial Update: Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

View source ↗

Summary

This document provides a Mayo Clinic-sponsored trial update on genetic analysis of blood and tumor samples from patients with advanced or metastatic ER-positive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Endocrine therapy
• Palbociclib (palbociclib)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Breast Carcinoma, Locally Advanced Breast Carcinoma | Status: ACTIVE_NOT_RECRUITING